Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

TRAIL-R1 (human) monoclonal antibody (HS101) (ATTO 647N conjugate)

ALX-804-297TS-T100 100 tests ATTO 647N 523.00 USD
Do you need bulk/larger quantities?

Product Details

Alternative Name:TRAIL receptor 1, Apo-2, CD261, DR4, Death receptor 4, TNFRSF 10A, TNF-related apoptosis-inducing ligand receptor 1, Tumor necrosis factor receptor superfamily member 10A
Immunogen:Recombinant human TRAIL-R1.
UniProt ID:O00220
GenBank ID:U90875
Gene/Protein Identifier:8797 (Entrez GeneID)
Species reactivity:Human
Crossreactivity:Does not cross-react with human TRAIL-R2, -R3 or -R4.
Applications:Flow Cytometry, ICC
Recommended Dilutions/Conditions:Flow Cytometry (1:200)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Formulation:Liquid. 100µg in PBS containing 0.02% sodium azide.
Handling:Do not freeze. Protect from light.
Shipping:Blue Ice
Short Term Storage:+4°C
Long Term Storage:+4°C
Scientific Background:TRAIL-R1 is a receptor for the cytotoxic ligand TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-κB.
Technical Info/Product Notes:ATTO-fluorescent antibodies show increased photostability, outstanding brightness and intense signals. ATTO dyes are thermally stable, resistant to environmental changes and show no significant isomerization. ATTO 647N shows red fluorescence (λabs (max): 645nm, λem (max): 669nm, εmax: 120’000).
Regulatory Status:RUO - Research Use Only

Product Literature References

A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members: Y. He, et al.; Sci. Rep. 7, 13301 (2017), Abstract; Full Text
Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression: E. Contassot, et al.; Blood 111, 4780 (2008), Abstract;
Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex: K. Izeradjene, et al.; Cancer Res. 64, 8036 (2004), Abstract; Full Text
cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes: T. Wachter, et al.; J. Biol. Chem. 279, 52824 (2004), Abstract; Full Text
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs: T.M. Ganten, et al.; Cell Death Differ. 11 Suppl 1, S86 (2004), Abstract;
IFN{alpha}-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells: C. Tecchio, et al.; Blood 103, 3837 (2004), Abstract;
TRAIL regulates normal erythroid maturation through an ERK-dependent pathway: P. Secchiero, et al.; Blood 103, 517 (2004), Abstract;
Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation: M. Leverkus, et al.; Mol. Cell. Biol. 23, 777 (2003), Abstract; Full Text
TNF-Related Apoptosis-Inducing Ligand Mediates Tumoricidal Activity of Human Monocytes Stimulated by Newcastle Disease Virus: B. Washburn, et al.; J. Immunol. 170, 1814 (2003), Abstract;
Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8: M.R. Sprick, et al.; EMBO J. 21, 4520 (2002), Abstract;
Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling in Activated T Cells Abrogates TRAIL-Induced Apoptosis Upstream of the Mitochondrial Amplification Loop and Caspase-8: T.S. Soderstrom, et al.; J. Immunol. 169, 2851 (2002), Abstract;

Related Products

TRAIL-R1 (human) monoclonal antibody (DJR1) 

Flow Cytometry, WB | Print as PDF
ALX-804-912-0100 100 µg 264.00 USD
Do you need bulk/larger quantities?

TRAIL-R1 polyclonal antibody 

WB | Print as PDF
BML-SA225-0100 100 µg 470.00 USD
Do you need bulk/larger quantities?

Product Toolbox


Certificate of Analysis


By target:
TRAIL receptor
By biological activity:
TRAIL receptor Monoclonal antibody
By catalog section:


Technical Service
Customer Service